Coherus BioSciences, Inc. (CHRS) Social Stream
COHERUS BIOSCIENCES INC (CHRS) Price Targets From Analysts
Use the tables below to see what analysts covering COHERUS BIOSCIENCES INC think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-17 | 7 | $30 | $19 | $24.666 | $2.62 | 841.45% |
| 2022-01-27 | 6 | $30 | $16 | $24.166 | $2.62 | 822.37% |
| 2022-02-18 | 6 | $30 | $16 | $23.666 | $2.62 | 803.28% |
| 2022-02-22 | 6 | $30 | $15 | $23.5 | $2.62 | 796.95% |
| 2022-03-07 | 6 | $30 | $15 | $22.666 | $2.62 | 765.11% |
| 2022-03-30 | 5 | $30 | $15 | $22.833 | $2.62 | 771.49% |
| 2022-04-13 | 5 | $30 | $15 | $22.666 | $2.62 | 765.11% |
| 2022-05-09 | 5 | $30 | $13 | $20.2 | $2.62 | 670.99% |
| 2022-05-20 | 4 | $30 | $13 | $21 | $2.62 | 701.53% |
| 2022-06-03 | 6 | $30 | $13 | $20.428 | $2.62 | 679.69% |
| 2022-08-01 | 6 | $30 | $7 | $18.5 | $2.62 | 606.11% |
| 2022-10-14 | 7 | $30 | $7 | $19.125 | $2.62 | 629.96% |
| 2022-11-09 | 6 | $30 | $7 | $19 | $2.62 | 625.19% |
| 2022-11-14 | 7 | $30 | $7 | $18.75 | $2.62 | 615.65% |
| 2022-11-16 | 7 | $30 | $7 | $17.875 | $2.62 | 582.25% |
| 2022-11-18 | 7 | $30 | $7 | $17.625 | $2.62 | 572.71% |
| 2022-12-16 | 7 | $30 | $7 | $17.375 | $2.62 | 563.17% |
| 2023-02-24 | 6 | $30 | $7 | $17.25 | $2.62 | 558.4% |
| 2023-03-07 | 7 | $30 | $7 | $16.625 | $2.62 | 534.54% |
| 2023-03-08 | 8 | $30 | $7 | $16.375 | $2.62 | 525% |
| 2023-03-14 | 8 | $30 | $7 | $16.625 | $2.62 | 534.54% |
| 2023-04-17 | 8 | $30 | $9 | $17.125 | $2.62 | 553.63% |
| 2023-04-24 | 9 | $30.001 | $9 | $17.125 | $2.62 | 553.63% |
| 2023-05-08 | 9 | $30.001 | $9 | $17.889 | $2.62 | 582.79% |
| 2023-05-10 | 9 | $30.001 | $9 | $17.555 | $2.62 | 570.04% |
| 2023-05-17 | 9 | $24 | $9 | $15.555 | $2.62 | 493.7% |
| 2023-05-23 | 9 | $24 | $8 | $15 | $2.62 | 472.52% |
| 2023-05-25 | 8 | $24 | $8 | $14.888 | $2.62 | 468.24% |
| 2023-06-06 | 9 | $24 | $8 | $14.888 | $2.62 | 468.24% |
| 2023-06-20 | 7 | $24 | $8 | $13.625 | $2.62 | 420.04% |
| 2023-07-14 | 7 | $24 | $8 | $14 | $2.62 | 434.35% |
| 2023-07-18 | 8 | $24 | $8 | $14 | $2.62 | 434.35% |
| 2023-07-24 | 9 | $24 | $8 | $13.75 | $2.62 | 424.81% |
| 2023-08-04 | 9 | $20 | $7 | $13.125 | $2.62 | 400.95% |
| 2023-10-12 | 9 | $20 | $6 | $13 | $2.62 | 396.18% |
| 2023-10-23 | 9 | $20 | $6 | $12.875 | $2.62 | 391.41% |
| 2023-10-30 | 9 | $20 | $6 | $13.125 | $2.62 | 400.95% |
| 2023-11-07 | 9 | $15 | $4 | $11 | $2.62 | 319.85% |
| 2023-11-08 | 9 | $15 | $4 | $11 | $2.62 | 319.85% |
| 2023-11-10 | 9 | $15 | $4 | $10.625 | $2.62 | 305.53% |
| 2023-11-17 | 10 | $15 | $4 | $10.5 | $2.62 | 300.76% |
The Trend in the Analyst Price Target
CHRS's average price target has moved down $7.06 over the prior 27 weeks.
CHRS reports an average of 221.49% for its upside potential over the past 42 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-02-24 | 7 | 30.000 | 7 | 17.250 | 6.94 | 148.56% |
| 2023-02-24 | 6 | 30.000 | 7 | 17.250 | 6.94 | 148.56% |
| 2023-03-07 | 7 | 30.000 | 7 | 16.625 | 7.30 | 127.74% |
| 2023-05-01 | 9 | 30.001 | 9 | 17.889 | 7.67 | 133.23% |
| 2023-10-12 | 9 | 20.000 | 6 | 13.000 | 3.69 | 252.3% |
CHRS Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.6 | 7 | 0 | 3 | 0 | 0 | 10 |
The Trend in the Broker Recommendations
Over the past 14 months, CHRS's average broker recommendation rating improved by 0.19.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- CHRS has a higher upside potential (average analyst target price relative to current price) than 5099.01% of all US stocks.
- CHRS has a lower variance in analysts' estimates than -4560.78% of all US stocks.
- CHRS has a greater number of analysts covering the stock than 4314.5% of stocks in the small market cap category.
- In terms of how COHERUS BIOSCIENCES INC fares relative to Healthcare stocks, note that its average analyst price target is higher than 1646.69% of that group.
In the Pharmaceutical Products industry, ATRA, CGEN, and ONVO are the three stocks most similar to COHERUS BIOSCIENCES INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
What is the outlook for CHRS? Use POWR Ratings for clearer insight into price direction.